Clinical Trial Update: REducing Diabetic MacrovascUlar Complications DuE to Peripheral Arterial Disease- REDUCE-PAD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for REDUCE-PAD evaluating strategies to reduce macrovascular complications in adults with type 2 diabetes and peripheral arteria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: National Heart Centre Singapore | Conditions: Diabetes Mellitus, Type 2, Peripheral Arterial Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING